Alternatives to Dendro Technologies

AI-powered platform for understanding disease biology and accelerating drug discovery.

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

InvenireX is developing ultra-sensitive nucleic acid detection instrumentation for life sciences research.

Astradyne is a startup focused on developing advanced AI for scientific discovery and research.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

AI safety and research company building reliable, interpretable, and steerable AI systems.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Integrated drug development solutions for pharmaceutical and biotechnology companies, from preclinical to clinical trials.

Leveraging the adaptive immune system to diagnose and treat disease.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Physics-based software platform for molecular discovery and design in life and materials sciences.

Global life sciences company providing diagnostic and biopharma laboratory services.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

AI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.

Develops a computational model of the human body for drug discovery and development.

Global contract research, development, and manufacturing organization for pharmaceutical and biopharmaceutical industries.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Global CRDMO providing integrated R&D and manufacturing services for the pharmaceutical and life sciences industries.

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

A global oncology company developing and commercializing innovative cancer treatments.

AI-powered spatial biology platform for precision medicine and drug development.

AI-guided drug discovery platform for tissue-targeted medicines.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

AI-driven digital twin of embryo development for cell-based therapies.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

AI-driven drug discovery platform accelerating breakthrough scientific research.

Remote-controlled micro-robots for precise treatment of central nervous system disorders.

Developing engineered biologics to harness the immune system for disease treatment.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Biotech company using genomics and AI to discover novel small-molecule medicines from microbial genomes.

AI-powered platform for designing novel molecular structures for new medicines.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Ukko is developing novel food allergy and disorder treatments using advanced immunology and plant science.

AI-powered research assistant for scientific literature review and data extraction.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

AI-driven drug discovery platform for rapid development of novel therapeutics.

Lunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.

Leveraging quantum mechanics for accelerated molecular simulations in drug discovery.

Pasqal develops quantum computing solutions for complex scientific and industrial problems.

Mapping cell-cell communication at scale in human tissue.

Global supplier of life science research tools, including antibodies, reagents, and assays.

AI-driven drug discovery company developing novel medicines for unmet patient needs.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Quantum software company enabling breakthroughs in chemistry, materials science, and life sciences.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.